3 results
* Primary objective: To determine the effect of 78-weeks therapy with omalizumab compared to placebo on the number of sub-epithelial eosinophils, a marker of airway inflammation, in patients with persistent moderate to severe allergic asthma. *…
The aim of this research is twofold:1) Determining the functionality of the oxygen sensor in the neck (the glomus body or *carotid body* during the administration of glucose and insulin, a so-called euglycemic hyperinsular clamp.2) Validating a new…
The overall objective of the CAB LA + RPV LA clinical development programme is to develop a highly effective, well-tolerated, two-drug, long-acting injectable regimen which has the potential to offer improved treatment convenience, compliance and…